IFOSFAMIDE - PHARMACOLOGY, SAFETY AND THERAPEUTIC POTENTIAL

被引：259

作者：

BRADE, WP ^{[1
]}

HERDRICH, K ^{[1
]}

VARINI, M ^{[1
]}

机构：

[1] OSPED SAN GIOVANNI, DIV ONCOL, CH-6500 BELLINZONA, SWITZERLAND

来源：

关键词：

D O I：

10.1016/0305-7372(85)90011-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1 / 47

页数：47

共 301 条

[1]

ABEL HH, 1977, 1977 P INT HOL S DUS

[2]

AHMANN DL, 1982, P AM ASS CANCER RES, V15

[3]

AIGINGER P, 1982, BLUT, V45, P222

[4]

AIGINGER P, 1982, 13TH P INT CANC C SE, P180

[5]

ALLEN LM, 1975, CLIN PHARMACOL THER, V17, P492

[6]

ALLEN LM, 1972, CANCER CHEMOTH REP 1, V56, P603

[7]

ALLEN LM, 1976, CANCER TREAT REP, V60, P451

[8]

ANDO K, 1981, HISHINOHAN HINYOKIKA, V43, P1299

[9]

ARAUJO C, 1982, 13TH P INT CANC C SE, P351

ARAUJO, CE ;

TESSLER, J .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (02) :195-201